丸通过干扰流感病毒复制的能力而作用。该药应在几周内提供。

分享pinterest.
抗流感药物Xofluza的发展今年早些时候在日本宣布。盖蒂张照片

Every year, the seasonal flu virus infects5到20％美国人可以导致成千上万的死亡。去年，80,000人死亡归因于病毒。

尽管令伤害流感每年需要，但很少有新的方式来反对它。

Today, however, the U.S. Food and Drug Administration (FDA) announced that they’ve approved the drug baloxavir marboxil (Xofluza) to treat influenza.

“This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” said FDA Commissioner Dr. Scott Gottlieb in a statement 。“With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option.”

日本制药公司announced今年早些时候流感治疗的发展。

临床试验始于今年夏天在美国。这first resultswere announced in September.

12月底预计FDA批准，但原子能机构宣布Xofluza批准，而不是该批准。

当我们进入流感季的中间时，这就是你需要了解新药丸的东西。

这medication is approved for people over the age of 12.

释放该药物的Genentech表示，它将在未来几周内广泛使用。

处方药只应在流感症状的前48小时内服用。

这antiviral drug helps stop the influenza virus from replicating.

它必须在症状的前48小时内施用，以便有效。

纽约的Lennox Hill医院急诊室医生罗伯特Glost博士解释说，该药物通过中断病毒复制的能力作用。

It disrupts this cycle earlier than current antiviral medications, such as Tamiflu.

“这次恢复了一步，并在很多步骤中迅速停止再现病毒和病毒复制，”Glatter告诉了健康的线条。雷竞技app官网

在多次临床试验发现它减轻流感症状并帮助缩短这些症状的持续时间后，FDA批准了这种药物。

While Xofluza works to stop viral replication earlier than Tamiflu, Glatter points out that the outcomes between people taking Tamiflu or Xofluza were similar.

“当小塔楼的48小时内开始治疗ming sick with flu symptoms, antiviral drugs can lessen symptoms and shorten the time patients feel sick,” said Dr. Debra Birnkrant, director of the division of antiviral products in the FDA’s Center for Drug Evaluation and Research. “Having more treatment options that work in different ways to attack the virus is important, because flu viruses can become resistant to antiviral drugs.”

这top side effects found in the studies were diarrhea and bronchitis, according to the FDA.

Viliam Schaffner博士，Vanderbilt University Center的传染病专家，位于田纳西州Vanderbilt大学医学中心，称，研究人员发现了药物导致一些流感菌株抵抗抗病毒药物，类似于细菌如何抵抗抗生素。

“在治疗那些流感感染时，它似乎似乎非常好，但抗性似乎正在易于发展，”Schaffner说。“那些抗性病毒可以传递给他人......这不是塔米菲的问题。”

Schaffner还说，治疗流感B型，春季通常会变得更加占主导地位，可能需要更多的药物。

格拉特和Schaffner都强调流感疫苗仍然是今年冬天保护自己免受流感的最佳方式。

“疫苗有助于降低流感的并发症以及流感的强度，”格拉特说。

Even if you end up contracting the flu after getting the vaccine, it “reduces the chance of complications, especially pneumonia,” Glatter said.

在20年来的第一次，有一种新的流感药物可用。

称为Xofluza的药物有助于阻止复制身体内的流感病毒。

Instead of multiple pills over days, Xofluza can be administered in just one pill.

副作用包括腹泻和支气管炎。

有些专家涉及它可能导致某些流感类型发育抗病毒性。

治疗应在未来几周内提供。